In addition, COVID-19 patients with chronic immune-mediated inflammatory diseases, such as IPF, are characterized by inherent immune dysfunction that leads to the release of cytokines, including IL-8 and disease severity [29, 30]. The gene discussed is CXCL8; the disease is idiopathic pulmonary fibrosis.